- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03856671
Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs
April 3, 2023 updated by: Hongbo Wei, Third Affiliated Hospital, Sun Yat-Sen University
Prophylatic Effect of Preoperative Antibiotics With Mechanical Bowel Preparation Compare With Simple Mechanical Bowel Preparation Before Laparoscopic Colorectal Surgery: a Randomized Controlled Trial
Surgical site infection (SSI) is a major postoperative complication after abdominal surgery especially in colorectal field, which significantly increases length of stay (LOS), readmission incidence and expense.
Therefore, identification of the effective method to reduce SSI incidence is critically important.
Combination of oral antibiotics and mechanical bowel preparation was reported with lower SSIs and LOS in some retrospecitve data analysis, however a prospective randmized controlled trial was absent.
Herein, the current randomized controlled trial comparing MBP+OA with MBP alone in postoperative complications in order to guide clinical practise was conducted.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Surgical site infection (SSI) is a major postoperative complication after abdominal surgery especially in colorectal field, which significantly increases length of stay (LOS), readmission incidence and expense.
Therefore, identification of the effective method to reduce SSI incidence is critically important.
Colonic bacterial flora is the major cause of SSIs after elective colorectal procedures.
For more than century, preoperative mechanical bowel preparation (MBP) has been utilized as it could theoretically decrease bacterial load within the surgical field, thus reduce risk of SSIs.
Later afterwards with widely application of antibiotics, combination of oral antibiotics (OA) and MBP was conducted by surgeons to further decrease rates of SSIs.
But SSIs still occurs despite of forehead mentioned methods, the best bowel preparation mode remains controversial.
Since 2005, several RCTs and meta-analysises demonstrated MBP alone was not associated with reduced SSIs compared with no bowel preparation, while postoperative ileus, anastomotic leakage and other complications incidence increased paradoxically.
Nevertheless, function of preoperative oral antibiotics remains debated.
Recently, combination of oral antibiotics and MBP has been evaluated in several retrospective studies and demonstrated a significant decrease in the rate of SSIs.
However, bias existence in these trials may affect result as information was exacted from national database without detailed matching.
Herein, current randomized controlled trial comparing MBP+OA with MBP alone in postoperative complications in order to guide clinical practise was conducted.
Study Type
Interventional
Enrollment (Actual)
309
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guanzhou, Guangdong, China, 510000
- The Third Affiliated Hospital of Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Older than 18 years old,
- Undergoing laparoscopic colorectal surgery due to malignancy.
Exclusion Criteria:
- No elective surgery
- Intra-abdominal infection
- Combination of other infectious surgery such as appendectomy, cholecystomy
- Sever comobidity such as uncontrolled hypertention and diabetes mellitus
- Peritoneal implantation and matastasis
- Radiotherapy history.
- Colorectal surgery due to benign lesions
- Allergic to antibiotics or PEG
- Preoperative dermatosis may interfere wound healing
- Long time application of corticosteroid
- Autoimmune disease may affect wound healing
- Patients refuse to enroll
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: oral antibiotics+mechanical bowel preparation
Liquid diet and polyethylene glycol with 2L water was administrated orally 1 day before surgery.
A combination of neomycin 1g and metronidazole 0.2g every 6 hours was also administrated.
Enteroclysis was conduted for patients on surgical morning.
|
Orally intake neomycin 1g and metronidazole 0.2g four times before surgery
|
|
No Intervention: simple mechanical bowel preparation
Only liquid diet and polyethylene glycol with 2L water was administrated orally 1 day before surgery.
Enteroclysis was conduted for patients on surgical morning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgical site infection incidence
Time Frame: 30 days after surgery
|
Include the superficial, deep and organ space infection.
|
30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antibiotics associated complications
Time Frame: 30 days after surgery
|
Allergy, antibiotics associated diarrhea
|
30 days after surgery
|
|
Length of hospital stay after surgery
Time Frame: 30 days after surgery
|
Length of hospital stay
|
30 days after surgery
|
|
Bowel recovery time
Time Frame: 7 days after surgery
|
Time interval from surgery to flatus and defecation
|
7 days after surgery
|
|
Other posteroperative complications
Time Frame: 30 days after surgery
|
Ilues, DVT, anastomotic fistula, hemorrhage, pulmonary infection
|
30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Hongbo Wei, Ph.D, Third Affiliated Hospital, Sun Yat-Sen University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 17, 2019
Primary Completion (Actual)
December 30, 2022
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
February 25, 2019
First Submitted That Met QC Criteria
February 25, 2019
First Posted (Actual)
February 27, 2019
Study Record Updates
Last Update Posted (Actual)
April 5, 2023
Last Update Submitted That Met QC Criteria
April 3, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Wound Infection
- Postoperative Complications
- Surgical Wound Infection
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Anti-Bacterial Agents
- Protein Synthesis Inhibitors
- Antiprotozoal Agents
- Antiparasitic Agents
- Metronidazole
- Neomycin
Other Study ID Numbers
- OAMBP-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Complications
-
Twin Cities Spine CenterAllina Health SystemRecruitingComplications, PostoperativeUnited States
-
Marmara UniversityHacettepe University; Cukurova University; Gazi University; Baskent University; Istanbul... and other collaboratorsNot yet recruitingComplications, PostoperativeTurkey
-
Syed HusainCompletedComplications, PostoperativeUnited States
-
Yale UniversityRecruitingPostoperative Complications (Cardiopulmonary)United States
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
Vastra Gotaland RegionRecruitingSurgery | Lung Infection | Complications, PostoperativeSweden
-
University of PittsburghCompletedLiver Transplant; Complications | Perioperative/Postoperative ComplicationsUnited States
-
Chi Mei Medical HospitalCompletedPostoperative Respiratory Complications | Pain, Postoperative.Taiwan
-
Fujian Medical University Union HospitalNot yet recruitingPostoperative Pulmonary Complications
-
COPAL - My JourneyRecruiting
Clinical Trials on Neomycin,metronidazole
-
Helsinki University Central HospitalActive, not recruiting
-
Najwa ElnachefCompletedUlcerative ColitisUnited States
-
Uzsoki HospitalUniversity of Debrecen; Csolnoky Ferenc HospitalRecruitingAnastomotic Leak | Microbial ColonizationHungary
-
University of ChicagoWithdrawnRectal Cancer | Anastomotic Leak
-
Ottawa Hospital Research InstituteActive, not recruiting
-
Universität LuzernNot yet recruitingSurgical Site Infection | Surgical Site Infections | Colon SurgerySwitzerland
-
Emory UniversityCompleted
-
LAMB ProjectCompletedWounds and Injuries | Skin Transplantation | Antibiotic Prophylaxis SurgeryBangladesh
-
Thomas Jefferson UniversityUnknownColorectal Neoplasms | Inflammatory Bowel Diseases | Surgical Site Infection | DiverticulitisUnited States
-
Mahidol UniversityRecruitingColonization, AsymptomaticThailand